Prostate Cancer Patients’ PSA Levels Altered By Statins

Beyond lowering cholesterol, statin medications have been found to have numerous other health benefits, including lowering a healthy man’s risk of developing advanced prostate cancer, as well as lowering his prostate-specific antigen (PSA) levels. But a new study by researchers at Henry Ford Hospital finds that statins also can lower PSA levels in men with prostate cancer, potentially altering the results of a patient’s PSA test and masking his risk for prostate cancer.

More: continued here

Filed under: Prostate on May 3rd, 2009